Small CRISPR RNAs guide antiviral defense in prokaryotes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18703739.
- Also identified by DOI 10.1126/science.1159689 and PMC identifier 5898235.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic acid into clusters of regularly interspaced short palindromic repeats (CRISPRs). Here we show how virus-derived sequences contained in CRISPRs are used by CRISPR-associated (Cas) proteins from the host to mediate an antiviral response that counteracts infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products containing the virus-derived sequence. Assisted by the helicase Cas3, these mature CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with virus proliferation. Our results demonstrate that the formation of mature guide RNAs by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement for antiviral defense.
Medical subject headings
- Bacteriophage lambda
- Escherichia coli K12
- Escherichia coli Proteins
- Repetitive Sequences, Nucleic Acid
- RNA, Bacterial